Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Sandmann S, Unger T
L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil
Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201

PDF    Summary    Overview   

First Image Fig. 3A-C: Kalziumkanal - Mibefradil Fig. 4: Kalziumkanal - Mibefradil Fig. 5: Kalziumkanal - Mibefradil This Image - Fig. 6: Kalziumkanal - Mibefradil Fig. 7: Kalziumkanal - Mibefradil Fig. 8A-B: Kalziumkanal - Mibefradil Fig. 9: Kalziumkanal - Mibefradil Last Image
Figure/Graphic 6: Kalziumkanal - Mibefradil
Inhibition of proliferation of CPAE cells by mibefradil. Cells were seeded in the absence (sqaure, control) and the presence of (circle) 1 microM, (triangle, peak up) 10 micorM and (triangle, peak down) 100 microM mibefradil. Inhibition of proliferation was significant at all concentrations. At 100 microM no living cells were present, at 10 microM adhesive cells could still be counted indicating true antiproliferative effects. Plotted are mean +/- SEM (vertical lines) at each day after seeding.
 
Kalziumkanal - Mibefradil
Previous Image Next Image   


Figure/Graphic 6: Kalziumkanal - Mibefradil
Inhibition of proliferation of CPAE cells by mibefradil. Cells were seeded in the absence (sqaure, control) and the presence of (circle) 1 microM, (triangle, peak up) 10 micorM and (triangle, peak down) 100 microM mibefradil. Inhibition of proliferation was significant at all concentrations. At 100 microM no living cells were present, at 10 microM adhesive cells could still be counted indicating true antiproliferative effects. Plotted are mean +/- SEM (vertical lines) at each day after seeding.
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung